Belrise Industries board meet Aug 14: Q1FY27, dividend

Board meeting date and key agenda

Belrise Industries Ltd (BSE: 544405, NSE: BELRISE) has informed the exchanges that its Board of Directors will meet on August 14, 2026. The agenda includes approval of unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. The board will also consider a proposal to increase the company’s authorised share capital. A third item on the agenda is the recommendation of a final dividend for FY2025-26 on equity shares issued and allotted under the company’s qualified institutions placement (QIP), subject to shareholder approval at the ensuing annual general meeting (AGM). The company will also fix a record date for the dividend, if recommended.

What the company told the exchanges

In its exchange intimation, Belrise stated that the board meeting is being called to consider and approve the June-quarter unaudited results for both standalone and consolidated accounts. Alongside this, it will take up the authorised share capital increase proposal, which typically precedes or supports capital-raising or corporate actions. On the dividend item, the company clarified that the final dividend recommendation is for FY2025-26 and relates to equity shares issued and allotted under QIP. Any such dividend would remain subject to member approval at the AGM, consistent with standard corporate governance practice. The record date decision is expected to follow the dividend recommendation, as record dates are used to determine eligible shareholders.

How this fits into recent corporate actions

The August 14 meeting comes after a period in which Belrise has undertaken multiple capital and corporate initiatives. Earlier disclosures referenced a board-approved fund raise of up to Rs 2,000.00 crore (Rs 20,000.00 million) through issuance of equity shares or other equity-linked instruments via QIP, subject to shareholder approval. The company has also disclosed board actions related to a scheme of amalgamation and other governance updates.

Another recent disclosure stated that the company received “no adverse observations” from the National Stock Exchange of India Limited and BSE Limited for its proposed scheme of amalgamation with Badve Autocomps Private Limited and Eximius Infra Tech Solutions Private Limited. Such exchange observations are a key procedural step for listed entities pursuing mergers, prior to the National Company Law Tribunal (NCLT) process.

Snapshot of the latest disclosed FY26 performance

Ahead of the June 2026 quarter update, Belrise’s previously disclosed FY26 numbers show growth in revenue and profit. The company’s consolidated revenue from operations for Q4FY26 was reported at Rs 2,552.83 crore (Rs 25,528.30 million), up 12.24% year-on-year from Rs 2,274.35 crore (Rs 22,743.48 million). FY26 consolidated revenue from operations was Rs 9,509.10 crore (Rs 95,091.02 million), up 14.69% from Rs 8,290.82 crore (Rs 82,908.16 million).

On the standalone side, Q4FY26 revenue from operations was disclosed at Rs 2,106.96 crore (Rs 21,069.63 million), up 17.11% year-on-year from Rs 1,799.11 crore (Rs 17,991.14 million). FY26 standalone revenue from operations stood at Rs 7,528.33 crore (Rs 75,283.30 million), a 14.17% increase over Rs 6,593.81 crore (Rs 65,938.07 million). Net profit for Q4FY26 was disclosed at Rs 130.23 crore (Rs 1,302.25 million) on a consolidated basis and Rs 136.27 crore (Rs 1,362.65 million) on a standalone basis.

Business mix disclosures from earlier quarterly updates

Belrise has previously shared operational detail alongside quarterly results. For Q3FY26, the company disclosed manufacturing revenue of Rs 2,340.50 crore (Rs 23,405 million), up 8% compared with Rs 2,166.80 crore (Rs 21,668 million) in Q3FY25. Manufacturing EBITDA for Q3FY26 was stated at Rs 257.90 crore (Rs 2,579 million), with manufacturing EBITDA margin of 14.0%. It also disclosed that exports contributed 5.8% to manufacturing revenue, and that 73.9% of manufacturing revenue came from powertrain-neutral products.

For Q1FY26, the company disclosed total revenue of Rs 2,262.21 crore (Rs 22,622.1 million), EBITDA of Rs 280.52 crore (Rs 2,805.2 million), PAT of Rs 111.68 crore (Rs 1,116.8 million), and EPS of Rs 1.5. These disclosures provide context for what investors may look for in the June 2026 quarter results, including revenue trajectory and margin trends.

Dividend context: what is already known

For FY ending March 31, 2026, Belrise previously disclosed that its board had recommended a final dividend of Rs 0.55 per equity share (11%). The August 14, 2026 meeting agenda specifically references a recommendation of final dividend for FY2025-26 on equity shares issued and allotted under QIP, and also includes fixing a record date. Investors typically track record dates closely because eligibility to receive the dividend depends on shareholding as of that date.

Timeline of recent meetings and disclosures

The company has had multiple board and shareholder-related events in recent quarters, including meetings for results and dividends.

Stock and listing identifiers in the disclosure

Belrise is listed on both the BSE and NSE with identifiers BSE: 544405 and NSE: BELRISE. The dataset also showed a price reference of ₹248.21 and an “Open” and “Previous Close” of ₹244.61, along with a displayed market capitalisation of ₹24,005.68. These figures were presented alongside the exchange-linked information in the provided extract.

Company and investor contact details

Belrise’s registered address in the extract is Plot No D-39, MIDC Area Waluj, Aurangabad, Maharashtra, 431133. The company’s compliance email is complianceofficer@belriseindustries.com and the website listed is http://www.belriseindustries.com. The registrar details included Link Intime India Private Limited, with an email rnt.helpdesk@linkintime.co.in and Mumbai address in the extract.

What to watch next

The immediate trigger for investors will be the outcome of the August 14, 2026 board meeting, including the June-quarter unaudited numbers and any decision on authorised share capital. Any dividend recommendation and the record date, if announced, will be another key disclosure because it determines shareholder eligibility. Updates related to the proposed amalgamation scheme may also remain in focus, given the company has already disclosed receipt of “no adverse observations” from NSE and BSE for the scheme.